Plant-Based Recombinant Protein Production Platform
Plant-produced recombinant proteins provide a sustainable and cost-effective alternative to traditional protein manufacturing methods. SignalChem leverages the potential of plants as bioreactors to optimize protein expression and recovery. Plants offer unique advantages, such as their innate inability to cause human diseases, making them ideal for producing orally administered antigens. These innovative approaches harness the full potential of plant-based systems, enabling robust and scalable production of recombinant proteins. This platform opens new avenues for applications in biotechnology and medicine.
Plant-Based Drug Discovery & Development Platform
SignalChem Plantech integrates its parent company’s advanced platform to conduct high-throughput screening of bioactive natural compounds. The primary focus lies in identifying and developing target-specific molecule clusters and individual molecules from medicinal plants.
Innovative Bio-Stimulant-Based Platform
SignalChem Plantech utilizes genomic insights to enhance the nutritional value of produce, herbs, and supplements through non-transgenic methods. Central to this effort is the development of an innovative bio-stimulant-based platform designed to amplify bioactive compounds in fruits, vegetables, and medicinal plants such as Chinese traditional herbs (TCM).